News for 'Development Control Regulations'

Adani Crisis: What RBI, SEBI Must Do

Adani Crisis: What RBI, SEBI Must Do

Rediff.com6 Mar 2023

In the context of market integrity, the IRAI and RBI should go over the minutes of the LIC and SBI board meetings when the decisions to invest in Adani equity or debt were taken, notes Jaimini Bhagwati, former World Bank treasury professional.

Show tight control over fiscal situation, populism: Kochhar

Show tight control over fiscal situation, populism: Kochhar

Rediff.com7 Jul 2014

Government needs tight control over both expenditure and populism.

DCGI approves Covovax for emergency use in 12-17 yrs age group

DCGI approves Covovax for emergency use in 12-17 yrs age group

Rediff.com9 Mar 2022

Confirming the Drugs Controller General Of India (DCGI) approval, Serum Institute of India CEO Adar Poonawalla on Tuesday tweeted: '@SerumInstIndia's brand Covovax has completed bridging studies in India and has been granted Emergency Use Authorisation by DCGI for adults and for children above the age of 12. Younger age groups will follow shortly.'

DCGI approves mRNA Covid jab for 18 yrs & above; Covovax for 7-11 yrs

DCGI approves mRNA Covid jab for 18 yrs & above; Covovax for 7-11 yrs

Rediff.com28 Jun 2022

The DCGI's nod came after the subject expert committee on COVID-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax for the age group of 7 to 11 years.

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Rediff.com17 Sep 2021

Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.

India at 75: 18 biggest moments for Indian markets from 1947 to 1993

India at 75: 18 biggest moments for Indian markets from 1947 to 1993

Rediff.com12 Aug 2022

From the enactment of the capital control Act to the recognition of the BSE as a stock exchange and the infamous Harshad Mehta scam, here are the 18 biggest events for stock markets from 1947 to 1993.

Housing sales to breach pre-pandemic levels in 2022

Housing sales to breach pre-pandemic levels in 2022

Rediff.com21 Aug 2022

India's residential market is expected to sustain demand momentum despite rise in mortgage and property rates as sales this year across the top 7 cities are likely to breach pre-pandemic level of 2.62 lakh units, industry players said. After braving four back-to-back disruptions in form of demonetisation, RERA, GST and COVID-19 in the last 6 years, industry experts feel the housing market is going through a lot of structural changes and is now at the start of a long-term upcycle. Homebuyers body FPCE gives credit to the Real Estate Regulatory Authority (RERA) under the Real Estate (Regulation & Development) Act, 2016 for this improved buying sentiment.

Pharma funds: 'Enter with a horizon of 5-7 years or more'

Pharma funds: 'Enter with a horizon of 5-7 years or more'

Rediff.com14 Mar 2023

In contrast with their strong performance in 2020 and 2021, pharmaceutical and healthcare funds experienced a decline in 2022, with returns plummeting by an average 9.8 per cent. This trend has continued in the current year, with year-to-date return remaining in the negative (-4.9 per cent). In the past three months, pharma funds have been hit hard, experiencing a 7.9 per cent decline.

Dr Reddy's gets warning from US health regulator

Dr Reddy's gets warning from US health regulator

Rediff.com7 Nov 2015

Dr Reddy's gets warning from US health regulator

SIIto test Novavax's Omicron-specific vaccine

SIIto test Novavax's Omicron-specific vaccine

Rediff.com6 Jun 2022

The Drugs Controller General of India has approved the manufacture of this Sars-CoV-2 spike protein recombinant nano-particle vaccine for 'examination, test, and analysis', reports Sohini Das.

Why India, other developing nations must exercise rights under the WTO

Why India, other developing nations must exercise rights under the WTO

Rediff.com8 Nov 2015

Protectionist and exclusionary FTAs weaken multilateralism.

Dom's Take: The Vaccine Dilemma

Dom's Take: The Vaccine Dilemma

Rediff.com9 Jan 2021

Dominic Xavier ponders the Vaccine Dilemma: Should he take the shot or not?

Days after Veep's criticism, CJI hails basic structure doctrine

Days after Veep's criticism, CJI hails basic structure doctrine

Rediff.com21 Jan 2023

The remarks by the CJI came against the backdrop of the recent remarks by Vice President Jagdeep Dhankhar who questioned the landmark 1973 Kesavananda Bharati case verdict that gave the basic structure doctrine.

Govt to amend 114-year-old the Indian Ports Act, bring in reforms

Govt to amend 114-year-old the Indian Ports Act, bring in reforms

Rediff.com19 Aug 2022

The Ministry of Ports, Shipping and Waterways has released a draft to amend the Indian Ports Act, 1908, which aims to bring in sweeping reforms in the sector by bringing non-major ports into the national fold, creating a new mechanism for resolution of disputes, and empowering maritime state development council (MSDC). The draft bill will see comments from stakeholders before being tabled in Parliament. "The Indian Ports Act, 1908 is more than 110 years old. It has become imperative that the Act is revamped to reflect the present-day frameworks, incorporate India's international obligations, address emerging environmental concerns, and aid the consultative development of the ports sector in the national interest," the shipping ministry said.

How complex is the process of getting approval for a vaccine?

How complex is the process of getting approval for a vaccine?

Rediff.com30 Sep 2020

Vaccine development is a long process to ensure safety and efficacy through different stages and involves regulatory supervision every step of the way. Ruchika Chitravanshi takes you through this carefully drawn journey of vaccine development.

Gen Rawat's chopper crashed due to 'entry into clouds': IAF report

Gen Rawat's chopper crashed due to 'entry into clouds': IAF report

Rediff.com14 Jan 2022

'The accident was a result of entry into clouds due to unexpected change in weather conditions in the valley. This led to spatial disorientation of the pilot resulting in Controlled Flight into Terrain (CFIT),' it stated.

DGCI approves Covaxin for phase 2/3 trials on children

DGCI approves Covaxin for phase 2/3 trials on children

Rediff.com13 May 2021

India's apex drug regulator has granted permission for conducting the phase II/III clinical trial of Bharat Biotech's Covaxin COVID-19 vaccine in the age group of 2 to 18 years, the Union Health Ministry said on Thursday.

Top realtors in race to enter one of world's priciest markets

Top realtors in race to enter one of world's priciest markets

Rediff.com30 Aug 2021

Some of the country's largest listed real estate developers - DLF, Prestige Estates, and Puravankara - are foraying into the Rs 50,000-crore residential property market of Mumbai, where home prices are among the highest in the world. All of them are set to launch residential projects in the financial capital of the country, where the market is dominated by players such as Runwal, Lodha, and Oberoi Realty, among others. Leading the race is Prestige, which has lined up 6 million square feet (msf) of new launches in the city across Mulund and Byculla in the third quarter of this financial year (2021-22).

CAG may pull up regulator, RIL in KG-D6 report

CAG may pull up regulator, RIL in KG-D6 report

Rediff.com25 Sep 2013

According to an official close to the development, in the coming financial audit report, to be tabled in Parliament's Budget session next year, CAG will detail the slide in the government's share in petroleum sector profits due to a drop in gas production.

China's Military Upgrade A Cause Of Concern

China's Military Upgrade A Cause Of Concern

Rediff.com28 Mar 2023

The further expansion and upgrade of the Chinese military does not augur well for India, which continues to confront an increasingly belligerent China on its borders, notes former foreign secretary Shyam Saran.

Where is China's Alibaba group founder Jack Ma?

Where is China's Alibaba group founder Jack Ma?

Rediff.com4 Jan 2021

Chinese billionaire and Alibaba group founder Jack Ma is suspected to be missing following his mysterious disappearance from the public eye for over two months after Beijing's aggressive crackdown on his business empire.

Bharat Biotech seeks emergency nod for use of Covaxin

Bharat Biotech seeks emergency nod for use of Covaxin

Rediff.com8 Dec 2020

Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

Adani row: Strengthen regulatory system to protect investors, SC tells govt

Adani row: Strengthen regulatory system to protect investors, SC tells govt

Rediff.com10 Feb 2023

The Supreme Court on Friday said there should be a robust mechanism to ensure that the interests of Indian investors are protected in the stock market and sought views of the Centre and market regulator SEBI on PILs alleging exploitation of innocent investors and "artificial crashing" of the Adani group's stock value.

Vikram-S opens new doors for India's space programme

Vikram-S opens new doors for India's space programme

Rediff.com18 Nov 2022

The 6-metre tall launch vehicle Vikram-S is named after Vikram Sarabhai, the father of the country's space programme and lifted off at 11.30 am.

Novovax Covid vaccine likely to get nod in India ahead of US

Novovax Covid vaccine likely to get nod in India ahead of US

Rediff.com18 Aug 2021

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending on DCGI approvals.

Serum's Covid vaccine, Covovax, recommended for approval

Serum's Covid vaccine, Covovax, recommended for approval

Rediff.com27 Dec 2021

The Pune-based firm had submitted interim safety and immunogenicity data of phase 2/3 bridging clinical trial conducted in the country as well as interim clinical trial data of safety and efficacy from phase3 clinical trials conducted in the UK and the US along with its application.

Theranos founder Elizabeth Holmes given 11-year jail for duping investors

Theranos founder Elizabeth Holmes given 11-year jail for duping investors

Rediff.com19 Nov 2022

She was found guilty in January of duping investors and lying about the technology after a three-month trial.

After Amazon, Flipkart fined for allowing sale of poor quality cookers

After Amazon, Flipkart fined for allowing sale of poor quality cookers

Rediff.com18 Aug 2022

The Central Consumer Protection Authority (CCPA) on Wednesday said it has imposed a penalty of Rs 1 lakh on e-commerce firm Flipkart for allowing sale of substandard domestic pressure cookers on its platform, in violation of mandatory standards. Headed by Chief Commissioner Nidhi Khare, the CCPA has directed Flipkart to recall all such 598 pressure cookers sold on its platform, reimburse their buyers, and submit a compliance report within 45 days. The central government routinely notifies the Quality Control Orders (QCOs), specifying compulsory conformity to a standard and use of the standard mark for a product to protect consumers from the risk of suffering injury and harm and in the interest of the public at large.

In 100 days, Shinde govt reverses Uddhav's half dozen decisions

In 100 days, Shinde govt reverses Uddhav's half dozen decisions

Rediff.com23 Oct 2022

Notably, after coming to power in November 2019, the then MVA government scrapped certain policy decisions of its predecessor BJP-Shiv Sena government led by Fadnavis.

Two years in, the hits and misses from the Fadnavis government

Two years in, the hits and misses from the Fadnavis government

Rediff.com2 Nov 2016

The government has received flak for allegedly shielding the corrupt ministers and slow pace of investigation in irrigation scam.

COVID-19: Mistakes World Must Avoid

COVID-19: Mistakes World Must Avoid

Rediff.com14 Jan 2022

If the pandemic persists, at least a portion of the blame should go to greed and nationalism that got in the way of the world acting together, notes Prosenjit Datta.

Cipla gets nod to import Moderna vaccine for emergency use in India

Cipla gets nod to import Moderna vaccine for emergency use in India

Rediff.com29 Jun 2021

India's drug regulator Drugs Controller General of India has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the country, official sources said on Tuesday.

Car prices to rise as auto cos gear to comply with stricter emission norms

Car prices to rise as auto cos gear to comply with stricter emission norms

Rediff.com9 Oct 2022

Passenger and commercial vehicle prices are expected to rise as automobile companies invest in upgrading vehicles to meet stricter emission norms that kick in from April next year. The Indian automobile industry is currently working to make their products meet the second phase of Bharat Stage VI, equivalent to Euro-VI emission norms, in real time driving conditions. Four-wheeler passenger and commercial vehicles will need more sophisticated equipment to be added to meet the next level of emission standards.

Covaxin gets nod for use in children above 12 years with riders

Covaxin gets nod for use in children above 12 years with riders

Rediff.com25 Dec 2021

The Subject Expert Committee on COVID-19 of the CDSCO on October 12 after deliberating Bharat Biotech's EUA application had recommended granting emergency use approval to Covaxin for use in the 12-18 years age group with certain conditions.

First nasal spray for treating Covid patients launched in India

First nasal spray for treating Covid patients launched in India

Rediff.com9 Feb 2022

The company claims that when the Nitric Oxide Nasal is sprayed over nasal mucosa it acts as a physical and chemical barrier against the virus.

Vaccine will be available to all

Vaccine will be available to all

Rediff.com17 Dec 2020

The vaccine would be first made available to the vulnerable population and eventually, it would be available in the private market for all.

Bio E gets nod for kids' phase 2, 3 Covid vax trial

Bio E gets nod for kids' phase 2, 3 Covid vax trial

Rediff.com3 Sep 2021

Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology (DBT) said on Friday.

Serum seeks emergency use for its COVID-19 vaccine

Serum seeks emergency use for its COVID-19 vaccine

Rediff.com7 Dec 2020

SII is the first indigenous company that has sought emergency approval for the vaccine developed along with global pharma giant AstraZeneca and Oxford University.

BJP can't win a single seat on its own in Tamil Nadu: Stalin

BJP can't win a single seat on its own in Tamil Nadu: Stalin

Rediff.com30 Dec 2022

Stalin said one cannot and should not decide the mood of the entire country based on the results of one state elections.

Only Covaxin available for 15-18-yr-olds, for now

Only Covaxin available for 15-18-yr-olds, for now

Rediff.com27 Dec 2021

Healthcare and frontline workers and citizens above 60 years of age with comorbidities would be administered the third dose of the same vaccine they had been given before.